Vinmec International Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Hanoi Vietnam (1993)

Organization Overview

First Clinical Trial
2014
NCT02627131
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

VINMEC | Vinmec Healthcare System | VinMec HS | Vinmec Research Institute of Stem Cell and Gene Technology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autistic Disorder (Phase 2)

Biliary Atresia (Phase 2)

Bronchopulmonary Dysplasia (Phase 1)

Cerebral Palsy (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Encephalitis (Phase 2)

Endocrine System Diseases (Phase 2)

Fibrosis (Phase 2)

Hyperplasia (Phase 1)

Jaundice (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Biliary (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Malaria, Falciparum (Phase 2)

Meningitis (Phase 2)

Paralysis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 29
  • # of Trial APIs: 13